Quick Takeaways
- Inscobee Inc. has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $8,805,900.
- Recent insider filing activity is available below.
- Info
- Significant Ownership
- Insider Ownership
Insider Trading & Ownership of Inscobee Inc.
- Location
- Seoul, Korea, Republic of
- Summary
- The estimated value of insider holdings of Inscobee Inc. is at least $8,805,900 dollars as of 11 Jun 2025. Inscobee Inc. is the 10%+ Owner of Apimeds Pharmaceuticals US, Inc. and owns shares of Apimeds Pharmaceuticals US, Inc. (APUS) stock worth about $8.81M.
- Signature
- /s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Inscobee Inc. and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Apimeds Pharmaceuticals US, Inc. ($8,805,900).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Inscobee Inc.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| APUS | Apimeds Pharmaceuticals US, Inc. | 10%+ Owner | $8,805,900 | 12 May 2025 |
Insider Transactions Reported by Inscobee Inc.:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.